Futura Medical plc (AIM:FUM)
0.5500
0.00 (0.00%)
Jun 16, 2026, 12:15 PM GMT
Futura Medical Revenue
In the year 2025, Futura Medical had annual revenue of 1.70M GBP, down -87.82%. Futura Medical had revenue of 695.51K in the half year ending December 31, 2025, a decrease of -50.23%.
Revenue
1.70M
Revenue Growth
-87.82%
P/S Ratio
1.88
Revenue / Employee
130.51K
Employees
14
Market Cap
3.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.70M | -12.23M | -87.82% |
| Dec 31, 2024 | 13.93M | 10.83M | 349.09% |
| Dec 31, 2023 | 3.10M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OptiBiotix Health | 1.17M |
| Oxford BioDynamics | 1.10M |
| Physiomics | 1.01M |
| Genflow Biosciences | 585.61K |
| BSF Enterprise | 52.84K |
| ValiRx | 49.78K |
| CRISM Therapeutics | 25.00K |
| Thalia Therapeutics | 7.07K |
Futura Medical News
- 11 days ago - AIM Market Roundup: Distil, Pantheon Resources, Metir - The Armchair Trader
- 6 weeks ago - Futura Medical Earnings Call Transcript: H2 2025 - Transcripts
- 6 weeks ago - Futura Medical Annual report: H2 2025 - Filings
- 6 weeks ago - Futura Medical Slides: H2 2025 - Filings
- 6 weeks ago - Futura Medical Annual report: H2 2025 - Filings
- 4 months ago - Futura Medical Earnings release: Q4 2025 - Filings
- 9 months ago - Futura Medical Earnings Call Transcript: H1 2025 - Transcripts
- 9 months ago - Futura Medical Quarterly report: H1 2025 - Filings